Veratramine
Cat. No.：YN482568
CAS No. ：60-70-8
| 产品名称: | Veratramine |
| CAS No.: | 60-70-8 |
| Chemical Name: | 5S-methyl-2S-[1S-[2,3S,4,6,6aR,11,11aS,11bR-octahydro-3R-hydroxy-10,11b-dimethyl-1H-benzo[a]fluoren-9-yl]ethyl]-3-piperidinol |
| Synonyms: | 黎芦碱; NSC17821; NSC23880 |
| 分子量: | 409.60 |
| 分子式: | C₂₇H₃₉NO₂ |
| SMILES: | O[C@H]1[C@H]([C@H](C2=C(C)C3=C(C=C2)[C@]4([H])CC=C(C[C@@H](O)CC5)[C@@]5(C)[C@@]4([H])C3)C)NC[C@@H](C)C1 |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Veratramine(NSC17821; NSC23880)是信号转导抑制剂，可作用于肿瘤。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Heretsch, P., Tzagkaroulaki, L., and Giannis, A.Cyclopamine and hedgehog signaling: Chemistry, biology, medical perspectivesAgnew. Chem. Int. Ed. Engl.49(20),3418-3427(2010)
Xu, F.G., Ma, Q.Y., and Wang, Z.Blockade of hedgehog signaling pathway as a therapeutic strategy for pancreatic cancerCancer Lett.283(2),119-124(2009)
Mahindroo, N., Punchihewa, C., and Fujii, N.Hedgehog-Gli signaling pathway inhibitors as anticancer agentsJ. Med. Chem.52(13),3829-3845(2009)
Tang, J., Li, H.L., Shen, Y.H., et al.Antitumor and antiplatelet activity of alkaloids from Veratrum dahuricumPhytother. Res.24(6),821-826(2010)
Nagata, R., Izumi, K., Iwata, S.i., et al.Mechanisms of veratramine-induced 5-HT syndrome in miceJpn. J. Pharmacol.55,139-146(1991)
Fukuma, K.Actions of veratramine on the central nervous systemJpn. J. Pharmacol.5,102-114(1956)
